Tirschwell & Loewy’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Tirschwell & Loewy’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-34,715	Closed	-$1.87M	–	81
2017 Q4	$1.87M	Sell	34,715 -1,522	-4%	-$83.3K	0.26%	46
2017 Q3	$2.07M	Sell	36,237 -235	-0.6%	-$13.8K	0.31%	43
2017 Q2	$2.19M	Sell	36,472 -733	-2%	-$41.7K	0.34%	43
2017 Q1	$2.03M	Buy	+37,205	New	+$1.83M	0.33%	48

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Tirschwell & Loewy's BIVV Position: Q1 2018 in Review

Tirschwell & Loewy sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 34,715 shares — an estimated $1.87M sold.

Tirschwell & Loewy first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.19M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Tirschwell & Loewy reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Tirschwell & Loewy sold 34,715 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.87M.
Tirschwell & Loewy first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Tirschwell & Loewy's Bioverativ Inc. Common Stock position peaked at $2.19M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Tirschwell & Loewy's 13F filing for Q1 2018, filed 16 Apr 2018.